Correlation Between Vascular Biogenics and Allarity Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vascular Biogenics and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vascular Biogenics and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vascular Biogenics and Allarity Therapeutics, you can compare the effects of market volatilities on Vascular Biogenics and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vascular Biogenics with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vascular Biogenics and Allarity Therapeutics.

Diversification Opportunities for Vascular Biogenics and Allarity Therapeutics

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vascular and Allarity is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Vascular Biogenics and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Vascular Biogenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vascular Biogenics are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Vascular Biogenics i.e., Vascular Biogenics and Allarity Therapeutics go up and down completely randomly.

Pair Corralation between Vascular Biogenics and Allarity Therapeutics

If you would invest  28.00  in Vascular Biogenics on October 7, 2024 and sell it today you would earn a total of  0.00  from holding Vascular Biogenics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy5.0%
ValuesDaily Returns

Vascular Biogenics  vs.  Allarity Therapeutics

 Performance 
       Timeline  
Vascular Biogenics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vascular Biogenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Vascular Biogenics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Allarity Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allarity Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's essential indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Vascular Biogenics and Allarity Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vascular Biogenics and Allarity Therapeutics

The main advantage of trading using opposite Vascular Biogenics and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vascular Biogenics position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.
The idea behind Vascular Biogenics and Allarity Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.